Finance

Lists
Why is OKUR down 12.62%?
Dive Deeper
OKUR:NASDAQ
Onkure Therapeutics Inc
$2.63
-12.62%
(-0.38) 1D
Nov 13, 4:00:01 PM GMT-5  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for OKUR...
Open
$3.03
High
$3.08
Low
$2.60
Mkt. cap
106.52M
Avg. vol.
382.96K
Volume
891.35K
52-wk high
$5.38
52-wk low
$2.01
EPS
-$2.77
Beta
0.18
Shares outstanding
40.50M
No. of employees
45
Open
$3.03
High
$3.08
Low
$2.60
Mkt. cap
106.52M
Avg. vol.
382.96K
Volume
891.35K
52-wk high
$5.38
52-wk low
$2.01
EPS
-$2.77
Beta
0.18
Shares outstanding
40.50M
No. of employees
45
News stories
From web sources and news partners
About Onkure Therapeutics Inc
CEO-
Employees45
Founded2011
HeadquartersBoulder, Colorado, United States
SectorHealth Care
IndustryBiotechnology
Websiteonkuretherapeutics.com
Analyst
Recommendation
Action
Price target
Projected
Date
Matthew Biegler
Oppenheimer
Buy
Reiterated
$14.00
+432.3%
08/14/2026
Leland Gershell
Oppenheimer
Buy
Reiterated
$14.00
+432.3%
08/14/2026
Sam Slutsky
LifeSci Capital
Buy
Maintained
$16.00
+508.4%
08/05/2026
Boris Peaker
JonesTrading
Hold
Maintained
-
-
08/05/2026
Robert Burns
H.C. Wainwright
Buy
Reiterated
$21.00
+698.5%
07/20/2026
Soumit Roy
JonesTrading
Buy
Maintained
$17.00
+546.4%
04/06/2026
Previous reportsAll values in USD
Loading Previous Earnings...
Revenue
Net income
All values in USD
Dec 2025
Mar 2026
Jun 2026
Sep 2026
Revenue
-
-
-
-
Cost of goods sold
-
-
-
-
Cost of revenue
-
-
-
-
Research and development expenses
10.72M
11.71M
12.61M
15.06M
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
3.40M
3.91M
4.29M
4.29M
Operating expense
14.12M
15.62M
16.90M
19.35M
Total operating expenses
14.12M
15.62M
16.90M
19.35M
Operating income
-14.12M
-15.62M
-16.90M
-19.35M
Other non operating income
-
-
-
-
EBT including unusual items
-13.50M
-15.16M
-15.35M
-17.85M
EBT excluding unusual items
-13.50M
-15.16M
-15.35M
-17.85M
Income tax expense
-
-
-
-
Effective tax rate
-
-
-
-
Other operating expenses
-
-
-
-
Net income
-13.50M
-15.16M
-15.35M
-17.85M
Net profit margin
-
-
-
-
Earnings per share
-0.99
-1.11
-0.31
-0.36
Interest and investment income
628.00K
458.00K
1.55M
1.50M
Interest expense
-6.00K
-
-
-
Net interest expenses
622.00K
458.00K
1.55M
1.50M
Depreciation and amortization charges
-
-
-
-
EBITDA
-14.02M
-15.51M
-16.81M
-19.30M
Gain or loss from assets sale
4.00K
-
-
-
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
Upcoming events
AI content may include mistakes. Learn more
HelpSend feedbackPrivacyTermsDisclaimer
Google apps